Quantcast

Latest Biogen Idec Stories

2013-09-30 23:27:33

Reportbuyer.com just published a new market research report: Multiple Sclerosis: KOL Insight. London (PRWEB) September 30, 2013 An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse future trends. The past year has seen landmark changes in multiple sclerosis, with the launch of two new novel oral products—Tecfidera (dimethyl fumarate; Biogen...

2013-09-08 23:01:44

Currently there are a number of disease-modifying drugs in the Multiple Sclerosis (MS) market that are indicated for the treatment of relapsing forms of the disease, specifically reducing the frequency of disease relapses. Dallas, Texas (PRWEB) September 08, 2013 The global multiple sclerosis therapeutics market has the potential to grow to a value of $17.9 billion by 2019. The market is currently led by Copaxone, which achieved global sales of $4 billion in 2012. Over the forecast period...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related